Evidence map›Paper›PMID 41560289›Full record

ArticleAnalytical chemistry2026

Extraction-Free Scalable Sample Preparation for the Rapid Detection of HIV in Blood Plasma.

Kelli N Shimazu, Andrew T Bender, Coleman Martin, Nandini Gummalla, Jonathan D Posner

Abstract read
In one paragraph

Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kelli N ShimazuDepartment of Mechanical Engineering, University of Washington, Seattle, Washington, 98195, United States.ORCID 0009-0005-5175-3357
Andrew T BenderDepartment of Mechanical Engineering, University of Washington, Seattle, Washington, 98195, United States.ORCID 0000-0003-4349-4488
Coleman MartinDepartment of Chemical Engineering, University of Washington, Seattle, Washington, 98195, United States.ORCID 0000-0003-4931-7677
Nandini GummallaDepartment of Biology, University of Washington, Seattle, Washington, 98195, United States.ORCID 0009-0006-5171-2114
Jonathan D PosnerDepartment of Mechanical Engineering, University of Washington, Seattle, Washington, 98195, United States.ORCID 0000-0001-8860-050X

Funding

Point-of-care Nucleic Acid Amplification Test for pangenomic Hepatitis C diagnosis in outpatient clinicsR01AI180936 · NIAID · UNIVERSITY OF WASHINGTON · PI Jonathan D Posner · 2024 to 2026
$2.3M
Electrokinetic paper diagnostic platform: 15-minute, quantitative nucleic acidamplification for viral pathogens in whole bloodR01EB022630 · NIBIB · UNIVERSITY OF WASHINGTON · PI POSNER, JONATHAN D · 2017 to 2020
$2.2M
Rapid, quantitative isothermal molecular assay for POC HIV-1 viral load monitoring using amplification nucleation site analysisR21AI179267 · NIAID · UNIVERSITY OF WASHINGTON · PI POSNER, JONATHAN D · 2023 to 2024
$428k
NIAID NIH HHS R01 AI180936NIAID NIH HHS R21 AI179267NIBIB NIH HHS R01 EB022630
6 · The paper itself

Abstract

Nucleic acid amplification tests that are rapid and low-cost are needed for expanding access to point-of-care (POC) diagnostics for infectious diseases and viral load monitoring. Several companies have commercialized POC devices using rapid isothermal amplification; however, these tests use nasal swabs or saliva samples. Translating these tests to blood plasma is challenging due to clotting factors, heat- or pH-induced coagulation of human albumin, high concentrations of ribonucleases (RNases), and other sample matrix inhibitors. Crude, extraction-free sample preparation methods are promising alternatives that reduce the complexity of sample preparation. In this paper, we present an extraction-free sample preparation method for in-tube and paper-based reverse transcription recombinase polymerase amplification for the detection of HIV in blood plasma samples. We use a rapid heat treatment protocol with a reducing agent to inhibit RNases and lyse HIV virus, enabling RNA preservation into direct amplification without the need for complex RNA purification steps. We demonstrate sample treatment in 5 min and amplification within 20 min in reaction volumes ranging from 50 to 300 μL and show that large volume reactions achieve a limit of detection of 800 copies/mL (16 copies/reaction) for HIV-positive plasma in both paper and tube formats.

Indexed as

HIVHIV-1HIV InfectionsNucleic Acid Amplification TechniquesRNA, ViralHumansRapid Diagnostic TestsRNA, Viral

Identifiers

PMID41560289
PMCPMC12875368

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.